Vijaya Diagnostic Centre Limited — Investor Meet, 10-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Vijaya Diagnostic Centre reported strong Q1 FY27 results: revenue grew 22.8% to 231 Cr, EBITDA 34% to 98 Cr (42.7% margin), and PAT 37.6% to 53 Cr. Growth was broad-based across geographies like Hyderabad (17%) and Pune (18%), driven by B2C focus and volume. The company commissioned a flagship Bengaluru hub with advanced imaging and plans 9 more hubs and 10-12 spokes, with 190-195 Cr capex. Management sees continued market share gains through integrated offerings and growing wellness packages. Confident in sustained high double-digit growth.